Closing the Daily Disposable Gap in Presbyopic Astigmatism

New multifocal toric daily disposable lens highlights a broader shift in how the profession is approaching one of its most complex – and common – patient groups

February 17, 2026
3 min

The Ophthalmologist

Overview

The launch of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM marks a significant advancement in the management of patients with both presbyopia and astigmatism. This is the first daily disposable multifocal toric lens available in the UK and Ireland, addressing a long-standing gap in the market.

Background

Astigmatism and presbyopia are common refractive errors that often coexist, complicating contact lens selection for affected patients. With presbyopia projected to impact up to 2.1 billion individuals globally by 2030, the need for effective and comfortable vision correction options is critical. The absence of daily disposable options for this demographic has historically led to high dropout rates among contact lens wearers.

Data Highlights

No numerical data available in the source material.

Key Findings

ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM is the first daily disposable multifocal toric lens in the UK and Ireland.
91% of patients achieved successful first-fit with the lens at their initial visit.
The lens is designed to provide clarity at multiple distances while ensuring comfort and stability throughout the day.
Johnson & Johnson has introduced updated fitting tools to assist practitioners in managing presbyopic astigmatism.
The lens will be showcased at 100% Optical in London, providing clinicians with an opportunity to review clinical data.

Clinical Implications

The introduction of this lens provides eye care professionals with a new tool to better meet the needs of patients with both presbyopia and astigmatism. Enhanced fitting tools may simplify the fitting process, potentially reducing dropout rates and improving patient satisfaction.

Conclusion

The launch of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM represents a significant step forward in addressing the needs of an underserved patient population, enhancing both comfort and visual performance.